Extracellular matrix: A gatekeeper in the transition from dormancy to metastatic growth

European Journal of Cancer

Volumn 46, Issue 7, 2010, Pages 1181-1188

  Barkan, Dalit ^a,b   Green, Jeffrey E ^b   Chambers, Ann F ^c  

^a UNIVERSITY OF HAIFA   (Israel)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Cell adhesion; Collagen; Cytoskeleton; Extracellular matrix; Fibronectins; Integrins; Metalloproteases; Neoplasm metastasis; Neoplasms; Recurrence

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BETA1 INTEGRIN; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; ENDOSTATIN; F ACTIN; FIBRONECTIN; GELATINASE A; GELATINASE B; INTEGRIN; KALININ; MACROPHAGE ELASTASE; MATRIX METALLOPROTEINASE; PROTEIN LYSINE 6 OXIDASE; PROTEIN P16; PROTEIN P27; RESTIN; RETINA S ANTIGEN; UROKINASE RECEPTOR; VASCULOTROPIN; VERY LATE ACTIVATION ANTIGEN 5;

ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CELL TYPE; EXTRACELLULAR MATRIX; HEAD AND NECK CARCINOMA; HUMAN; LUNG CARCINOMA; METASTASIS; MICROENVIRONMENT; PRIORITY JOURNAL; PROGNOSIS; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STOMACH CARCINOMA; STROMA CELL; TUMOR CELL;

CELL ADHESION; COLLAGEN; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; FIBRONECTINS; HUMANS; INTEGRINS; NEOPLASM METASTASIS; NEOPLASMS;

EID: 77950594400     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.02.027     Document Type: Article

References (74)

1. Aguirre-Ghiso J.A. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 7 11 (2007) 834-846
2. Pantel K., and Brakenhoff R.H. Dissecting the metastatic cascade. Nat Rev Cancer 4 6 (2004) 448-456
3. Naumov G.N., MacDonald I.C., Chambers A.F., et al. Solitary cancer cells as a possible source of tumour dormancy?. Semin Cancer Biol 11 4 (2001) 271-276
4. Townson J.L., and Chambers A.F. Dormancy of solitary metastatic cells. Cell Cycle 16 (2006) 1744-1750
5. Chambers A.F., Groom A.C., and MacDonald I.C. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2 8 (2002) 563-572
6. Naumov G.N., Townson J.L., MacDonald I.C., et al. Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases. Breast Cancer Res Treat 82 3 (2003) 199-206
7. Pantel K., Schlimok G., Braun S., et al. Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J Natl Cancer Inst 85 17 (1993) 1419-1424
8. Townson J.L., Ramadan S.S., Simedrea C., et al. Three-dimensional imaging and quantification of both solitary cells and metastases in whole mouse liver by magnetic resonance imaging. Cancer Res 69 (2009) 8336-8341
9. Wikman H., Vessella R., and Pantel K. Cancer micrometastasis and tumour dormancy. APMIS 116 7-8 (2008) 754-770
10. Holmgren L., O'Reilly M.S., and Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1 2 (1995) 149-153
11. Naumov G.N., Bender E., Zurakowski D., et al. A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype. J Natl Cancer Inst 98 5 (2006) 316-325
12. Koebel C.M., Vermi W., Swann J.B., et al. Adaptive immunity maintains occult cancer in an equilibrium state. Nature 450 7171 (2007) 903-907
13. Teng M.W., Swann J.B., Koebel C.M., et al. Immune-mediated dormancy: an equilibrium with cancer. J Leukoc Biol 84 4 (2008) 988-993
14. Demicheli R., Valagussa P., and Bonadonna G. Does surgery modify growth kinetics of breast cancer micrometastases?. Br J Cancer 85 4 (2001) 490-492
15. Braun S., Vogl F.D., Naume B., et al. A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med 353 8 (2005) 793-802
16. Goldberg S.F., Harms J.F., Quon K., et al. Metastasis-suppressed C8161 melanoma cells arrest in lung but fail to proliferate. Clin Exp Metastasis 17 7 (1999) 601-607
17. Naumov G.N., MacDonald I.C., Weinmeister P.M., et al. Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. Cancer Res 62 7 (2002) 2162-2168
18. Pantel K., Alix-Panabieres C., and Riethdorf S. Cancer micrometastases. Nat Rev Clin Oncol 6 6 (2009) 339-351
19. Podsypanina K., Du Y.C., Jechlinger M., et al. Seeding and propagation of untransformed mouse mammary cells in the lung. Science 321 5897 (2008) 1841-1844
20. Klein C.A., and Holzel D. Systemic cancer progression and tumor dormancy: mathematical models meet single cell genomics. Cell Cycle 5 16 (2006) 1788-1798
21. Bissell M.J., Rizki A., and Mian I.S. Tissue architecture: the ultimate regulator of breast epithelial function. Curr Opin Cell Biol 15 6 (2003) 753-762
22. Weaver V.M., Petersen O.W., Wang F., et al. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 137 1 (1997) 231-245
23. Debnath J., Muthuswamy S.K., and Brugge J.S. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30 3 (2003) 256-268
24. Nelson C.M., and Bissell M.J. Modeling dynamic reciprocity: engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation. Semin Cancer Biol 15 5 (2005) 342-352
25. Bissell M.J., Radisky D.C., Rizki A., et al. The organizing principle: microenvironmental influences in the normal and malignant breast. Differentiation 70 9-10 (2002) 537-546
26. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1 (1889) 99-101
27. Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev 8 2 (1989) 98-101
28. Goodison S., Kawai K., Hihara J., et al. Prolonged dormancy and site-specific growth potential of cancer cells spontaneously disseminated from nonmetastatic breast tumors as revealed by labeling with green fluorescent protein. Clin Cancer Res 9 10 Pt 1 (2003) 3808-3814
29. Fidler I.J. The organ microenvironment and cancer metastasis. Differentiation 70 9-10 (2002) 498-505
30. Gassmann P., Enns A., and Haier J. Role of tumor cell adhesion and migration in organ-specific metastasis formation. Onkologie 27 6 (2004) 577-582
31. White D.E., Rayment J.H., and Muller W.J. Addressing the role of cell adhesion in tumor cell dormancy. Cell Cycle 5 16 (2006) 1756-1759
32. Barkan D., Kleinman H., Simmons J.L., et al. Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res 68 15 (2008) 6241-6250
33. Henriet P., Zhong Z.D., Brooks P.C., et al. Contact with fibrillar collagen inhibits melanoma cell proliferation by up-regulating p27KIP1. Proc Natl Acad Sci USA 97 18 (2000) 10026-10031
34. Roth J.M., Akalu A., Zelmanovich A., et al. Recombinant alpha2(IV)NC1 domain inhibits tumor cell-extracellular matrix interactions, induces cellular senescence, and inhibits tumor growth in vivo. Am J Pathol 166 3 (2005) 901-911
35. Roskelley C.D., Desprez P.Y., and Bissell M.J. Extracellular matrix-dependent tissue-specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction. Proc Natl Acad Sci USA 91 26 (1994) 12378-12382
36. Shibue T., and Weinberg R.A. Integrin beta1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs. Proc Natl Acad Sci USA 106 25 (2009) 10290-10295
37. Aguirre-Ghiso J.A., Kovalski K., and Ossowski L. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling. J Cell Biol 147 1 (1999) 89-104
38. Aguirre-Ghiso J.A., Liu D., Mignatti A., et al. Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo. Mol Biol Cell 12 4 (2001) 863-879
39. White D.E., Kurpios N.A., Zuo D., et al. Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell 6 2 (2004) 159-170
40. Kren A., Baeriswyl V., Lehembre F., et al. Increased tumor cell dissemination and cellular senescence in the absence of beta1-integrin function. EMBO J 26 12 (2007) 2832-2842
41. Zahir N., Lakins J.N., Russell A., et al. Autocrine laminin-5 ligates alpha6beta4 integrin and activates RAC and NFkappaB to mediate anchorage-independent survival of mammary tumors. J Cell Biol 163 6 (2003) 1397-1407
42. Lock R., and Debnath J. Extracellular matrix regulation of autophagy. Curr Opin Cell Biol 20 5 (2008) 583-588
43. Lu Z., Luo R.Z., Lu Y., et al. The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. J Clin Invest 118 12 (2008) 3917-3929
44. Tlsty T.D., and Coussens L.M. Tumor stroma and regulation of cancer development. Annu Rev Pathol 1 (2006) 119-150
45. Jodele S., Blavier L., Yoon J.M., et al. Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression. Cancer Metastasis Rev 25 1 (2006) 35-43
46. Kaplan R.N., Rafii S., and Lyden D. Preparing the "soil": the premetastatic niche. Cancer Res 66 23 (2006) 11089-11093
47. Ramaswamy S., Ross K.N., Lander E.S., et al. A molecular signature of metastasis in primary solid tumors. Nat Genet 33 1 (2003) 49-54
48. Qiu T.H., Chandramouli G.V., Hunter K.W., et al. Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease. Cancer Res 64 17 (2004) 5973-5981
49. Feng Y., Sun B., Li X., et al. Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients. Breast Cancer Res Treat 103 3 (2007) 319-329
50. Calvo A., Catena R., Noble M.S., et al. Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis. Oncogene 27 40 (2008) 5373-5384
51. Ma X.J., Dahiya S., Richardson E., et al. Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res 11 1 (2009) R7
52. Chang H.Y., Nuyten D.S., Sneddon J.B., et al. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci USA 102 10 (2005) 3738-3743
53. Chang H.Y., Sneddon J.B., Alizadeh A.A., et al. Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol 2 2 (2004) E7
54. Kaplan R.N., Riba R.D., Zacharoulis S., et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438 7069 (2005) 820-827
55. Erler J.T., Bennewith K.L., Cox T.R., et al. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 15 1 (2009) 35-44
56. Albinger-Hegyi A, Stoeckli SJ, Schmid S, et al. Lysyl oxidase expression is an independent marker of prognosis and a predictor of lymph node metastasis in oral and oropharyngeal squamous cell carcinoma (OSCC). Int J Cancer, in press. [Epub ahead of print]. doi:10.1002/ijc.24948.
57. Jensen B.V., Johansen J.S., Skovsgaard T., et al. Extracellular matrix building marked by the N-terminal propeptide of procollagen type I reflect aggressiveness of recurrent breast cancer. Int J Cancer 98 4 (2002) 582-589
58. Park C.C., Rembert J., Chew K., et al. High mammographic breast density is independent predictor of local but not distant recurrence after lumpectomy and radiotherapy for invasive breast cancer. Int J Radiat Oncol Biol Phys 73 1 (2009) 75-79
59. Hasebe T., Sasaki S., Imoto S., et al. Prognostic significance of fibrotic focus in invasive ductal carcinoma of the breast: a prospective observational study. Mod Pathol 15 5 (2002) 502-516
60. Koyama T., Hasebe T., Tsuda H., et al. Histological factors associated with initial bone metastasis of invasive ductal carcinoma of the breast. Jpn J Cancer Res 90 3 (1999) 294-300
61. Paszek M.J., Zahir N., Johnson K.R., et al. Tensional homeostasis and the malignant phenotype. Cancer Cell 8 3 (2005) 241-254
62. Erler J.T., and Weaver V.M. Three-dimensional context regulation of metastasis. Clin Exp Metastasis 26 1 (2009) 35-49
63. Butcher D.T., Alliston T., and Weaver V.M. A tense situation: forcing tumour progression. Nat Rev Cancer 9 2 (2009) 108-122
64. Linskens M.H., Feng J., Andrews W.H., et al. Cataloging altered gene expression in young and senescent cells using enhanced differential display. Nucleic Acids Res 23 16 (1995) 3244-3251
65. Vlodavsky I., Goldshmidt O., Zcharia E., et al. Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development. Semin Cancer Biol 12 2 (2002) 121-129
66. O'Reilly M.S., Boehm T., Shing Y., et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88 2 (1997) 277-285
67. Ramchandran R., Dhanabal M., Volk R., et al. Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin. Biochem Biophys Res Commun 255 3 (1999) 735-739
68. Colorado P.C., Torre A., Kamphaus G., et al. Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res 60 9 (2000) 2520-2526
69. Maeshima Y., Colorado P.C., Torre A., et al. Distinct antitumor properties of a type IV collagen domain derived from basement membrane. J Biol Chem 275 28 (2000) 21340-21348
70. Houghton A.M., Grisolano J.L., Baumann M.L., et al. Macrophage elastase (matrix metalloproteinase-12) suppresses growth of lung metastases. Cancer Res 66 12 (2006) 6149-6155
71. Hattar R., Maller O., McDaniel S., et al. Tamoxifen induces pleiotrophic changes in mammary stroma resulting in extracellular matrix that suppresses transformed phenotypes. Breast Cancer Res 11 1 (2009) R5
72. Dallas S.L., Rosser J.L., Mundy G.R., et al. Proteolysis of latent transforming growth factor-beta (TGF-beta)-binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-beta from bone matrix. J Biol Chem 277 24 (2002) 21352-21360
73. Roy M., and Marchetti D. Cell surface heparan sulfate released by heparanase promotes melanoma cell migration and angiogenesis. J Cell Biochem 106 2 (2009) 200-209
74. Jin H., and Varner J. Integrins: roles in cancer development and as treatment targets. Br J Cancer 90 3 (2004) 561-565